Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 24
Filtre
1.
Rev. colomb. gastroenterol ; 37(2): 225-232, Jan.-June 2022. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1394954

Résumé

Abstract Graft-versus-host disease is a common complication after stem cell transplantation. The digestive tract is affected in many patients who suffer from it, with consequences that can be fatal. The proper approach, which includes endoscopic studies, allows ruling out differential diagnoses and managing the disease early.


Resumen La enfermedad de injerto contra huésped es una complicación frecuente después del trasplante de células madre. El tracto digestivo se afecta en una gran proporción de los pacientes que la sufren, con consecuencias que pueden llegar a ser fatales. El abordaje adecuado, que incluye el uso de estudios endoscópicos, permite descartar diagnósticos diferenciales y brindar un manejo temprano de la enfermedad.


Sujets)
Humains , Mâle , Femelle , Adolescent , Adulte , Transplantation de cellules souches/effets indésirables , Maladies gastro-intestinales/étiologie , Maladie du greffon contre l'hôte/diagnostic , Biopsie , Endoscopie gastrointestinale , Diagnostic différentiel , Maladies gastro-intestinales/anatomopathologie , Maladie du greffon contre l'hôte/anatomopathologie , Intestins/anatomopathologie
2.
Dermatol. argent ; 27(3): 119-122, jul.- sep. 2021. il, graf
Article Dans Espagnol | LILACS, BINACIS | ID: biblio-1373038

Résumé

El diagnóstico diferencial entre la enfermedad de injerto contra huésped aguda grave (estadio IV) y la necrólisis epidérmica tóxica pude resultar difícil en el contexto de un paciente trasplantado, ya que ambas tienen presentaciones clínicas similares. Sin embargo, la distinción entre ellas es fundamental porque ocasionan una gran morbimortalidad, y su manejo y pronóstico difieren. Algunas pequeñas diferencias clínicas e histopatológicas son de gran ayuda para el diagnóstico diferencial y el dermatólogo deberá reconocerlas para tomar una conducta correcta y oportuna. Se comunica el caso de un paciente que presentó ampollas y epidermólisis después del trasplante de células hematopoyéticas y en el que se planteó la dificultad diagnóstica para diferenciar entre ambas afecciones.


The differental diagnosis between severe graft-versus-host disease (stage IV) and toxic epidermal necrolysis can be difficult in the context of a transplant patient, since both conditions have similar clinical presentations. However, the distinction between these two entities is critical because they produce great morbidity and mortality and their management and prognosis differ. Some small clinical and histopathological differences are of great help for the differential diagnosis, and the dermatologist must recognize them in order to take a correct and timely conduct. We present the case of a patient who developed blisters and epidermolysis after hematopoietic cell transplantation, and in whom the diagnostic difficulty to differentiate between the two entities was raised.


Sujets)
Humains , Mâle , Adulte , Transplantation de cellules souches hématopoïétiques/effets indésirables , Maladie du greffon contre l'hôte/diagnostic , Méthylprednisolone/administration et posologie , Ciclosporine/administration et posologie , Maladie du greffon contre l'hôte/anatomopathologie , Maladie du greffon contre l'hôte/traitement médicamenteux , Sérum antilymphocyte
3.
Rev. latinoam. enferm. (Online) ; 23(4): 571-577, July-Aug. 2015. tab
Article Dans Anglais | LILACS, BDENF | ID: lil-761703

Résumé

AbstractObjective: to analyze the process of tissue repair in patients with venous ulcers using inelastic compression therapy (the Unna Boot), in comparison with the use of the elastic bandage.Method: a controlled randomized clinical trial in which the patients (n=18) were allocated to two groups, those who used the Unna Boot (group B) and those who used the elastic bandage (group A). The study's follow-up period was 13 weeks.Results: a significant reduction took place, at the level of 5%, in the area, in square centimeters, of the ulcers of group B (p<0.0001) throughout the treatment, and there was a tendency of group A for reduction in the area of the ulcer, in centimeters squared (p=0.06), only after the fifth week.Conclusion: the treatment with the Unna Boot presented better results in venous ulcers with areas over 10cm², and the elastic bandage with Petrolatum(r) gauze in venous ulcers below 10cm². Brazilian Clinical Trials Register: Trial (req: 195) and WHO UTN U1111-1122-5489.


ResumoObjetivo:analisar o processo de reparo tecidual de pacientes com úlcera venosa em uso da terapia compressiva inelástica (Bota de Unna), em comparação ao uso da bandagem elástica.Método:ensaio clínico controlado randomizado em que os pacientes (n=18) foram alocados em dois grupos, os que utilizavam a Bota de Unna (grupo B) e os que utilizavam a atadura elástica (grupo A). O tempo de seguimento da pesquisa foi de treze semanas.Resultados:ocorreu redução significativa, no nível de 5%, na área, em centímetros quadrados, das úlceras do grupo B (p<0,0001) ao longo de todo o tratamento, e tendência do grupo A à redução, na área da úlcera, em centímetros quadrados (p=0,06), apenas após a quinta semana.Conclusão:o tratamento com a Bota de Unna apresentou melhor resultado em úlceras venosas com áreas superiores a 10cm², e a atadura elástica com a gaze Petrolatum(r)em úlceras venosas inferiores a 10cm². Registro Brasileiro de Ensaios Clínicos: Trial (req: 195) e WHO UTN U1111-1122-5489.


ResumenObjetivo:analizar el proceso de reparación del tejido de pacientes con úlcera venosa que usan la terapia compresiva inelástica (Bota de Unna), en comparación con el uso del vendaje elástico.Método:ensayo clínico controlado aleatorio en que los pacientes (n=18) fueron designados en dos grupos, los que utilizaban la Bota de Unna (grupo B) y los que utilizaban el vendaje elástico (grupo A). El tiempo de duración de la investigación fue de trece semanas.Resultados:se constató reducción significativa, al nivel de 5%, en el área, en centímetros cuadrados, de las úlceras del grupo B (p<0,0001) a lo largo de todo el tratamiento; y tendencia del grupo A a la reducción, en el área de la úlcera, en centímetros cuadrados (p=0,06), solamente después de la quinta semana.Conclusión:el tratamiento con la Bota de Unna presentó mejor resultado en úlceras venosas con áreas superiores a 10cm², y el vendaje elástico con la gasa Petrolatum(r)en úlceras venosas inferiores a 10cm². Registro Brasileño de Ensayos Clínicos: Trial (req: 195) y WHO UTN U1111-1122-5489.


Sujets)
Animaux , Femelle , Souris , Maladie du greffon contre l'hôte , Tumeurs du rein , Transfusion de lymphocytes , Transplantation de cellules souches , Allogreffes , Lignée cellulaire tumorale , Maladie du greffon contre l'hôte/immunologie , Maladie du greffon contre l'hôte/anatomopathologie , Maladie du greffon contre l'hôte/thérapie , Tumeurs du rein/immunologie , Tumeurs du rein/anatomopathologie , Tumeurs du rein/thérapie , Souris de lignée BALB C , Souris de lignée DBA , Métastase tumorale
4.
An. bras. dermatol ; 89(4): 632-637, Jul-Aug/2014. tab, graf
Article Dans Anglais | LILACS | ID: lil-715521

Résumé

The graft-versus-host disease is the major cause of morbidity and mortality in patients who have undergone hematopoietic stem cell transplantation. Aiming at contributing to the understanding of the role of myeloid and plasmacytoid dendritic cells, and natural killer cells in chronic graft-versus-host disease, we examined biopsies of jugal mucosa of 26 patients with acute myeloid leukemia who had undergone allogenic hematopoietic stem cell transplantation. Half of these patients developed oral chronic graft-versus-host disease. Microscopic sections were immunohistochemically stained for anti-CD1a, anti-CD123 and anti-CD56. We calculated the number of immunostained cells in the corium per square millimeter and applied the Mann-Whitney test. Results showed a statistically significant increase of myeloid dendritic cells (CD1a+; p=0,02) and natural killer cells (CD56; p=0,04) in patients with oral chronic graft-versus-host disease. CD123 immunostaining showed no statistical difference between groups. It was concluded that myeloid dendritic cells and natural killer cells participate in the development of oral chronic graft-versus-host disease.


Sujets)
Femelle , Humains , Mâle , Jeune adulte , Cellules dendritiques/anatomopathologie , Maladie du greffon contre l'hôte/anatomopathologie , Transplantation de cellules souches hématopoïétiques , Cellules tueuses naturelles/anatomopathologie , Muqueuse de la bouche/anatomopathologie , Apoptose , Antigènes CD/immunologie , Biopsie , Numération cellulaire , Maladie chronique , Cellules dendritiques/immunologie , Maladie du greffon contre l'hôte/immunologie , Immunohistochimie , Cellules tueuses naturelles/immunologie , Leucémie aigüe myéloïde/immunologie , Leucémie aigüe myéloïde/anatomopathologie , Muqueuse de la bouche/immunologie , Statistique non paramétrique
5.
Einstein (Säo Paulo) ; 12(2): 204-210, Apr-Jun/2014. tab, graf
Article Dans Anglais | LILACS | ID: lil-713013

Résumé

Objective To validate the minimal criteria of the histopathologic diagnosis of oral chronic graft-versus-host disease, based on the histopathologic classification of the National Institutes of Health and correlate them with clinical features. Methods Forty-one specimens containing both oral mucosa and salivary glands were analyzed in slides stained with hematoxylin-eosin. The histological specimens were blindly examined by two trained pathologists using criteria recommended for the histopathologic diagnosis of chronic graft-versus-host disease proposed by the National Institutes of Health Consensus. The clinical classification of chronic graft-versus-host disease was correlated with analysis of slides. Results: Our data showed that the epithelium was involved in 39/41 specimens, presenting acanthosis (29/70.7%), exocytosis of lymphocytes (29/70.7%), thickening of basal lamina (29/70.7%), and apoptosis (15/36.6%). Connective tissue presented interstitial inflammatory infiltrate (38/92.7%). Minor salivary glands showed periductal fibrosis (38/92.7%), mixed periductal inflammatory infiltrate (32/78%), ductal ectasia (30/73.2%), lymphocytes around and into acinar units (30/73.2%), and interstitial fibrosis (29/70.7%). The most common clinical manifestations were lichenoid aspect (40/97.6%), complaints of sensitivity to oral feeding (38/92.7%), and dry mouth sensation (36/87.8%). Conclusion This study validated the National Institutes of Health Consensus of minimal histologic criteria for diagnosis of oral chronic graft-versus-host disease and has not found an association between the severity of clinical manifestation and the histopathological stage. .


Objetivo Validar os critérios mínimos de diagnóstico histopatológico da doença do enxerto contra hospedeiro crônica oral, com base em critérios de classificação do National Institutes of Health, e correlacioná-los com as características clínicas. Métodos Quarenta e um espécimes contendo mucosa oral e glândulas salivares foram analisados em lâminas coradas por hematoxilina-eosina. Os espécimes histológicos foram avaliados de forma cega, por dois patologistas calibrados, utilizando os critérios recomendados para diagnóstico histopatológico de doença do enxerto contra hospedeiro crônica propostos pelo Consenso do National Institutes of Health. A classificação clínica da doença do enxerto contra hospedeiro crônica foi correlacionada após a análise das lâminas. Resultados Nossos resultados mostraram que o epitélio estava comprometido em 39/41 espécimes, apresentando acantose (29/70,7%), exocitose de linfócitos (29/70,7%), espessamento da lâmina basal (29/70,7%) e apoptose (15/36,6%). O tecido conjuntivo apresentou infiltrado inflamatório intersticial em 38 (92,7%) casos. Nas glândulas salivares menores, observaram-se fibrose periductal (38/92,7%), infiltrado inflamatório periductal misto (32/78%), ectasia ductal (30/73,2%), linfócitos em torno e migrando para dentro dos ácinos (30/73,2%), e fibrose intersticial (29/70,7%). As manifestações clínicas mais comuns foram mucosa de aspecto liquenoide (40/97,6%), queixa de sensibilidade bucal ao se alimentar (38/92,7%), e sensação de boca seca (36/87,8%). Conclusão Os critérios mínimos para o diagnóstico histopatológico da doença do enxerto contra hospedeiro crônica oral, com base no Consenso do National Institutes of Health, foram ...


Sujets)
Humains , Maladie du greffon contre l'hôte/anatomopathologie , Transplantation de cellules souches hématopoïétiques/effets indésirables , Maladies de la glande salivaire/anatomopathologie , Biopsie , Maladie chronique , Consensus , Maladie du greffon contre l'hôte/classification , Maladie du greffon contre l'hôte/complications , Muqueuse de la bouche/anatomopathologie , National Institutes of Health (USA) , États-Unis
6.
An. bras. dermatol ; 88(5): 799-802, out. 2013. graf
Article Dans Anglais | LILACS | ID: lil-689725

Résumé

Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic. Chronic Graft-versus-host disease occurs in up to 70% of hematopoietic cell transplanted patients and its clinical manifestations have important impact on morbidity and quality of life. The authors report an expressive cutaneous, oral and adnexal involvement in a patient with chronic Graft-versus-host disease with multiple lesions of lichenoid and atrophic pattern.


Doença enxerto contra hospedeiro é observada principalmente em pacientes transplantados de células de origem hematopoiéticas e se expressa por sinais e sintomas cutâneos ou sistêmicos. Clinicamente, a Doença enxerto contra hospedeiro é classificada em aguda ou crônica. As do tipo crônico ocorrem em até 70% dos pacientes e suas manifestações têm impacto importante na morbidade e na qualidade de vida. Os autores relatam caso com extenso comprometimento cutâneo, oral e de anexos cutâneos em paciente com Doença enxerto contra hospedeiro crônica expressa por inúmeras lesões de padrão liquenóide e de atrofia cutânea.


Sujets)
Humains , Mâle , Adulte d'âge moyen , Maladie du greffon contre l'hôte/anatomopathologie , Éruption lichénoïde/anatomopathologie , Peau/anatomopathologie , Atrophie , Transplantation de moelle osseuse/effets indésirables , Maladie chronique
7.
Journal of Korean Medical Science ; : 106-113, 2013.
Article Dans Anglais | WPRIM | ID: wpr-188337

Résumé

Previous studies have shown that hematopoietic stem cell transplantation (HSCT) may result in growth impairment. The purpose of this study was to evaluate the growth during 5 yr after HSCT and to determine factors that influence final adult height (FAH). We retrospectively reviewed the medical records of acute myeloid leukemia (AML) patients who received HSCT. Among a total of 37 eligible patients, we selected 24 patients who began puberty at 5 yr after HSCT (Group 1) and 19 patients who reached FAH without relapse (Group 2). In Group 1, with younger age at HSCT, sex, steroid treatment, hypogonadism and hypothyroidism were not significantly associated with growth impairment 5 yr after HSCT. History of radiotherapy (RT) significantly impaired the 5 yr growth after HSCT. Chronic graft-versus-host disease (cGVHD) only temporarily impaired growth after HSCT. In Group 2, with younger age at HSCT, steroid treatment and hypogonadism did not significantly reduce FAH. History of RT significantly reduced FAH. Growth impairment after HSCT may occur in AML patients, but in patients without a history of RT, growth impairment seemed to be temporary and was mitigated by catch-up growth.


Sujets)
Adolescent , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Nourrisson , Mâle , Taille/effets des radiations , Maladie du greffon contre l'hôte/anatomopathologie , Transplantation de cellules souches hématopoïétiques , Hypogonadisme/traitement médicamenteux , Leucémie aigüe myéloïde/radiothérapie , Récidive , Études rétrospectives , Facteurs de risque , Stéroïdes/usage thérapeutique
8.
Dermatol. peru ; 22(4): 161-170, oct.-dic. 2012. ilus
Article Dans Espagnol | LILACS, LIPECS | ID: lil-712844

Résumé

La enfermedad injerto versus huésped (EIVH) es una entidad de frecuente presentación en las personas que son intervenidas con alotrasplantes. Es inducida y mantenida por las células inmunocompetentes del injerto, que atacan los tejidos del huésped; especialmente los epitelios. El diagnóstico de la EIVH es clínico, apoyado en la histopatología, pero esta, por sí misma, no permite diagnosticar la entidad. La primera línea de tratamiento de la EIVH continúan siendo los esteroides sistémicos y ante refractariedad para estos, aparecen nuevas terapéuticas que resultan efectivas en casos reportados en la literatura, sin que aún se hayan podido definir guías de manejo para este tipo de pacientes. Se necesita realizar estudios de terapéutica en pacientes refractarios a esteroides para poder concluir al respecto.


Graft versus host disease is a condition of frequent occurrence in people who are implanted with allogeneic transplants. The diagnosis is clinical, supported by histopathology, but this, by itself does not make a diagnosis. The first line of treatment for this entity are systemic steroids. For the patient refractory to systemic steroids, new therapeutics that could be useful are reported, but not yet defined its use and none were superior to steroids. Studies are needed to define the approach to the patient refractory to steroids.


Sujets)
Humains , Mâle , Femelle , Maladie du greffon contre l'hôte/classification , Maladie du greffon contre l'hôte/diagnostic , Maladie du greffon contre l'hôte/histoire , Maladie du greffon contre l'hôte/anatomopathologie , Maladie du greffon contre l'hôte/prévention et contrôle , Maladie du greffon contre l'hôte/thérapie , Épithélium , Lymphocytes
10.
Bauru; s.n; 2011. 110 p. ilus, tab, graf.
Thèse Dans Portugais | LILACS, BBO | ID: biblio-865851

Résumé

A doença enxerto contra hospedeiro (GVHD) é uma complicação comum nos pacientes submetidos ao transplante de células-tronco hematopoiéticas (TCTH), sendo considerada a maior causa de morbidade e mortalidade nesses pacientes. O principal objetivo do presente estudo foi relacionar a concentração de células de Langerhans em mucosa bucal de pacientes com GVHDc bucal com a expressão da quimiocina CCL20 e de seu receptor CCR6 no epitélio bucal, a fim de elucidar os mecanismos biológicos envolvidos no recrutamento das células de Langerhans na GVHDc. Foram selecionados fragmentos obtidos por biópsia de mucosa bucal de 60 pacientes onco-hematológicos e hematológicos submetidos previamente ao transplante de células tronco hematopoiéticas no Hospital Amaral Carvalho, Jaú SP, onde 30 pacientes desenvolveram GVHDc em mucosa bucal (Grupo 1) e 30 não desenvolveram GVHDc (Grupo 2). Amostras obtidas a partir de 30 biópsias de lesões não inflamatórias em mucosa bucal constituíram o Grupo Controle (Grupo 3). Cortes microscópicos foram avaliados em coloração de rotina Hematoxilina e Eosina, e submetidos à técnica imuno-histoquímica, utilizando-se anticorpos monoclonais anti-CD1a e anti-CCR6, e anticorpos policlonais anti-CCL20. As células de Langerhans CD1a+ foram quantificadas no epitélio da mucosa bucal, e os resultados demonstraram um maior número destas células nos pacientes com GVHDc quando comparados àqueles sem GVHDc e ao Grupo Controle (p<0,001). A análise da imunomarcação das moléculas CCR6 e CCL20 foi subjetiva com aplicação de escores. Quanto à molécula CCR6, houve maior expressão no Grupo 1 (p<0,001) em comparação aos outros Grupos; porém, quanto à expressão de CCL20, não houve diferença estatística entre os três Grupos (p=0,108). Estes resultados sugerem que o aumento das células de Langerhans, na doença enxerto contra hospedeiro crônica, em mucosa bucal, pode estar associado a maior expressão do receptor CCR6. Possivelmente, o maior recrutamento de células de...


The graft versus host disease (GVHD) is a common complication in patients undergoing hematopoietic stem cell transplantation (HSCT), and considered a major cause of morbidity and mortality in these patients. The main objective of this study was to compare the concentration of Langerhans cells in oral mucosa of patients with oral chronic GVHD (GVHDc) with the expression of the chemokine CCL20 and its receptor CCR6 in oral epithelium, in order to clarify the biological mechanisms involved in the recruitment of Langerhans cells in GVHDc. We selected 60 biopsies of oral mucosa from onco-hematological and hematological patients submitted to prior hematopoietic stem cell transplantation at Hospital Amaral Carvalho, Jaú - SP from which 30 patients developed GVHDc in the oral mucosa (Group 1) and 30 did not develop GVHDc (Group 2). The Control Group (Group 3) was obtained from 30 biopsies of non-inflammatory lesions of oral mucosa. Microscopic sections were evaluated in routine Hematoxylin and Eosin staining, and submitted to immunohistochemistry using anti-CD1a and anti-CCR6 monoclonal antibodies, and anti-CCL20 polyclonal antibody. The Langerhans cells (CD1a+) were quantified in the epithelium of the oral mucosa, and the results showed a greater number of these cells in patients with GVHDc compared to those without GVHDc and the Control Group (p<0.001). Analysis of immunostaining of molecules CCL20 and CCR6 were subjective with application of scores. The expression of CCR6 molecule was more significant in Group 1 (p<0.001) compared to other groups, but in relation to CCL20 expression, there was no statistical difference between the three groups (p=0.108). These results suggest that the increase of Langerhans cells in GVHDc affecting oral mucosa may be associated with increased expression of the receptor CCR6. We suggest that the increased recruitment of Langerhans cells to the oral mucosa in patients with transplanted bone marrow contributes...


Sujets)
Humains , Mâle , Femelle , Adulte , Cellules de Langerhans/anatomopathologie , Maladie du greffon contre l'hôte/anatomopathologie , Muqueuse de la bouche/anatomopathologie , Chimiokines/biosynthèse , /biosynthèse , Biopsie , Maladie du greffon contre l'hôte/métabolisme , Marqueurs biologiques/métabolisme , Muqueuse de la bouche/métabolisme , Répartition par sexe , Statistique non paramétrique , Transplantation de cellules souches hématopoïétiques/effets indésirables
12.
Dermatol. argent ; 16(4): 252-260, 2010. ilus
Article Dans Espagnol | LILACS | ID: lil-626087

Résumé

Debido al incremento en la utilización del trasplante alogénico de médula ósea como terapéutica, es cada vez más frecuente observar la enfermedad injerto contra huésped como una de sus complicaciones de mayor relevancia. Ésta suele ser una causa importante de morbimortalidad en los pacientes trasplantados. Las manifestaciones cutáneas generalmente son las primeras en aparecer, y tanto su forma aguda como crónica presentan una gran variedad clínica. El objetivo de este trabajo es revisar la etiología, las características clínicas e histopatológicas, el diagnóstico y la terapéutica de la enfermedad de injerto contra huésped cutánea.


Sujets)
Humains , Maladie du greffon contre l'hôte/classification , Maladie du greffon contre l'hôte/physiopathologie , Maladie du greffon contre l'hôte/anatomopathologie , Maladie du greffon contre l'hôte/traitement médicamenteux , Transplantation de moelle osseuse , Glucocorticoïdes , Immunosuppresseurs , Photophérèse , Pharmacothérapie administrée en bolus , Transplantation homologue/effets indésirables
13.
Rev. chil. pediatr ; 78(5): 500-510, oct. 2007. ilus, tab
Article Dans Espagnol | LILACS | ID: lil-482861

Résumé

Background: Transfusion-associated graft versus host disease (AT-GVDH) is produced by an aggressive host inmune response secondary to the incorporation and proliferation of T lymphocytes in blood products. AT-GVDH affects immunocompromised patients with cellular immune dysfunction, but also immunocompetent persons with certain genetic characteristics. It presents as an acute syndrome that involves skin, gastrointestinal tract, liver and bone marrow. The use of irradiated blood products represents the only therapeutic choice. Objective: To describe a severe and rarely diagnosed pathological condition associated to frequent clinical practice. Case-report: A 6 months-old child with a severe combined immunodeficiency (pathology with high risk of AT-GVDH) who developed this disease after a filtered red blood cell transfusion. Conclusions: The AT-GVDH is an uncommon iatrogenic and highly lethal complication related to the use of blood products. It implies high degree of clinical suspicion because underlying pathologies of risk may be unknown. The therapy is poor, being prevention the only available alternative. It is fundamental to know the risks and complications in using blood products, in order to determine correctly their indications.


Introducción: La Enfermedad Injerto Contra Huésped asociada a Transfusiones (EICH-AT) se produce por una respuesta inadecuada y autodestructiva del organismo frente a la incorporación y proliferación de linfocitos T presentes en los hemoderivados. Afecta fundamentalmente a pacientes inmunosuprimidos de predominio celular, aunque también a inmunocompetentes con determinadas características genéticas. Se manifiesta como un síndrome agudo que compromete piel, hígado, tracto gastrointestinal y médula ósea, confundible al inicio con enfermedades banales frecuentes. Actualmente la prevención, mediante el uso de hemoderivados irradiados representa la única medida terapéutica demostrada. Objetivo: Presentar una entidad patológica grave y poco reconocida asociada a una práctica clínica habitual. Caso clínico: Lactante de 6!4 meses portadora de una Inmunodeficiencia Combinada Severa que posterior a una transfusión de glóbulos rojos filtrados desarrolló esta enfermedad. Conclusiones: La EICH-AT es una complicación iatrogénica infrecuente, altamente letal y potencialmente prevenible relacionada a la administración de hemoderivados. Requiere un alto grado de sospecha clínica, mas aun en menores de 1 año en quienes pueden desconocerse patologías de riesgo subyacentes.


Sujets)
Humains , Femelle , Nourrisson , Maladie du greffon contre l'hôte/étiologie , Transfusion sanguine/effets indésirables , Médicaments Dérivés du Sang , Évolution Clinique , Maladie du greffon contre l'hôte/diagnostic , Maladie du greffon contre l'hôte/physiopathologie , Maladie du greffon contre l'hôte/anatomopathologie , Issue fatale , Sujet immunodéprimé , Facteurs de risque
14.
Arq. neuropsiquiatr ; 65(3a): 700-704, set. 2007. tab
Article Dans Anglais | LILACS | ID: lil-460815

Résumé

The chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an unusual but important complication of hematopoietic stem cell transplantation (HSCT) rarely reported to date. We describe a 17-year-old woman with a diagnosis of acute myeloid leukemia due to Fanconi's anemia who was submitted to allogeneic HSCT and developed CIDP as part of graft-versus-host disease. Investigation showed high cerebrospinal fluid protein; electrophysiological studies revealed sensory-motor demyelinating polyradiculoneuropathy; muscle and nerve biopsy were compatible with CIDP.


A polirradiculoneuropatia desmielinizante inflamatória crônica (CIDP) é uma incomum, porém, importante complicação do transplante de células hematopoiéticas (HSCT) raramente relatada até a data. Nós descrevemos uma mulher de 17 anos com diagnóstico de leucemia mielóide aguda por anemia de Fanconi que foi submetida à HSCT e desenvolveu CIDP como parte da doença do enxerto contra o hospedeiro. A investigação mostrou elevação na proteína no líquor; estudo eletrofisiológico revelando polirradiculoneuropatia desmielinizante sensitivo-motora; e biópsia de músculo e nervo compatível com CIDP.


Sujets)
Adolescent , Femelle , Humains , Maladie du greffon contre l'hôte/étiologie , Transplantation de cellules souches hématopoïétiques/effets indésirables , Polyradiculonévrite inflammatoire démyélinisante chronique/étiologie , Biopsie , Transplantation de moelle osseuse/effets indésirables , Maladie du greffon contre l'hôte/anatomopathologie , Leucémie aigüe myéloïde/chirurgie , Motoneurones/anatomopathologie , Polyradiculonévrite inflammatoire démyélinisante chronique/anatomopathologie , Nerfs spinaux/anatomopathologie
15.
Braz. oral res ; 20(3): 191-195, Jul.-Sept. 2006. tab
Article Dans Anglais, Portugais | LILACS | ID: lil-435805

Résumé

This study was designed to investigate the impact of haematopoietic stem cell transplantation (HSCT) on Helicobacter pylori colonization of the oral mucosa by nested polymerase chain reaction (nested-PCR). Forty six consecutive patients submitted to HSCT and 46 healthy volunteers were included in the study. Oral swabs were taken from the oral mucosa of the patients and control group. The medical records of the patients were reviewed and the following information was retrieved: gender and age of the patient, donor gender, primary disease, stem cell source (bone marrow or blood stem cells), leukocyte, neutrophil and platelet counts, and chronic graft versus host disease (cGVHD) of salivary glands. The results demonstrated an increased frequency of H. pylori in the oral mucosa of HSCT patients compared to controls (rho = 0.002). The presence of H. pylori in the oral mucosa was not related to the severity of cGVHD. The median counts of platelet/mm³, leukocytes/mm³ and neutrophils/mm³ in the group of HSCT patients positive for H. pylori were not statistically different from those of the patients negative for it. In conclusion, the present study shows increased frequency of H. pylori in the oral mucosa of HSCT patients compared to non-transplanted healthy volunteers.


O objetivo do estudo é investigar o impacto do transplante de células-tronco hematopoiéticas (TCTH) na colonização da mucosa bucal pela Helicobacter pylori através do "nested-PCR". Quarenta e seis pacientes submetidos ao TCTH e 46 indivíduos saudáveis foram incluídos no estudo. Raspados de mucosa bucal foram realizados nos pacientes do grupo de estudo e grupo controle. Os dados médicos dos pacientes foram revisados e as seguintes informações foram coletadas: gênero e idade do paciente, gênero do doador, doença primária, fonte de células-tronco (medula óssea ou células-tronco sanguíneas), número de leucócitos, neutrófilos e plaquetas, doença do enxerto contra o hospedeiro crônica (DECHc) de glândulas salivares. Os resultados demonstram aumento na freqüência de H. pylori na mucosa bucal de pacientes submetidos ao TCTH comparado com grupo controle (r = 0.002). A presença da H. pylori na mucosa bucal não teve relação com a severidade da DECHc. As medianas de número de plaquetas/mm³, leucócitos/mm³ e neutrófilos/mm³ no grupo de pacientes TCTH positivos para H. pylori não foram estatisticamente diferentes das medianas dos pacientes negativos. Concluindo, o presente estudo mostra um aumento da freqüência da H. pylori na mucosa bucal de pacientes submetidos ao TCTH quando comparada com a de um grupo de voluntários não transplantados saudáveis.


Sujets)
Humains , Mâle , Femelle , Enfant , Adolescent , Adulte , Adulte d'âge moyen , Maladie du greffon contre l'hôte/microbiologie , Infections à Helicobacter/complications , Helicobacter pylori/isolement et purification , Muqueuse de la bouche/microbiologie , État de porteur sain , Études cas-témoins , Électrophorèse sur gel d'agar , Maladies gastro-intestinales/microbiologie , Maladies gastro-intestinales/anatomopathologie , Maladie du greffon contre l'hôte/immunologie , Maladie du greffon contre l'hôte/anatomopathologie , Helicobacter pylori/génétique , Transplantation de cellules souches hématopoïétiques/effets indésirables , Transplantation de cellules souches hématopoïétiques/normes , Sujet immunodéprimé , Muqueuse de la bouche/anatomopathologie , Réaction de polymérisation en chaîne , Facteurs de risque , Statistique non paramétrique , Donneurs de tissus
17.
Rev. chil. dermatol ; 22(3): 170-176, 2006. ilus, tab
Article Dans Espagnol | LILACS | ID: lil-460844

Résumé

La enfermedad de Injerto contra Huésped (EICH) es una cuadro que se produce en algunos de los pacientes receptores de un trasplante de médula ósea, en el cual los linfocitos T inmunocompetentes del tejido trasplantado reaccionan en contra de los tejidos del receptor (huésped). Se divide en dos grandes grupos: agudo y crónico. Sus manifestaciones clínicas son diversas, dadas por el compromiso variable de piel, hígado, tracto gastrointestinal, entre otros. Las lesiones cutáneas suelen ser el hallazgos más frecuente tanto en la forma aguda como crónica. Dada la existencia de múltiples procesos patológicos que pueden simular una EIDCH, su diagnóstico requiere, además de un alto índice de sospecha, el estudio histológico y el seguimiento cercano de los pacientes. Dado que cada vez son más frecuentes los trasplantes de médula ósea, así como sus manifestaciones más habituales y precoces ocurren en la piel, es muy importante para los dermatólogos estar familiarizados con este cuadro clínico.


Sujets)
Mâle , Adulte , Humains , Maladie du greffon contre l'hôte/complications , Maladie du greffon contre l'hôte/anatomopathologie , Maladies de la peau/immunologie , Transplantation de moelle osseuse/effets indésirables , Maladie aigüe , Maladie chronique , Maladie du greffon contre l'hôte/classification , Maladie du greffon contre l'hôte/thérapie
18.
Rev. chil. radiol ; 11(3): 134-137, 2005. ilus
Article Dans Espagnol | LILACS | ID: lil-449912

Résumé

La enfermedad de injerto contra huésped es un síndrome que ocurre en pacientes inmuno-deprimidos generalmente post-trasplante de médula ósea, caracterizado en su etapa aguda por manifestaciones dermatológicas, hepáticas y gastrointestinales. El diagnóstico oportuno es fundamental, ya que puede disminuir significativamente la morbimortalidad. Dentro del diagnóstico diferencial de las manifestaciones gastrointestinales se incluye enterocolitis neutropénica y colitis pseudomembranosa. Mediante tomografía computada, hay signos que apuntan a su diagnóstico, como dilatación focal de asas, y refuerzo significativo de la mucosa enterocólica.


Sujets)
Humains , Maladie du greffon contre l'hôte/complications , Maladie du greffon contre l'hôte/diagnostic , Entérocolite/diagnostic , Entérocolite/étiologie , Coloscopie , Diagnostic différentiel , Maladie du greffon contre l'hôte/anatomopathologie , Maladies gastro-intestinales/diagnostic , Maladies gastro-intestinales/étiologie , Sujet immunodéprimé , Neutropénie , Syndrome , Tomodensitométrie , Transplantation de moelle osseuse/effets indésirables
19.
The Korean Journal of Hepatology ; : 319-321, 2004.
Article Dans Coréen | WPRIM | ID: wpr-82373
20.
Journal of Korean Medical Science ; : 191-195, 2003.
Article Dans Anglais | WPRIM | ID: wpr-126083

Résumé

We conducted a retrospective study to investigate the incidence, risk factors, and clinical features of hemorrhagic cystitis (HC) following allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients who developed HC after allo-HCT were identified from the HCT database of the Asan Medical Center and their medical records were reviewed. From December 1993 to August 2001, a total of 210 adult patients underwent allo-HCT. Fifty-one patients developed HC with a cumulative incidence of 25.7%. The median onset of HC was post-transplant day 24 (range, -2 to 474), and the median duration was 31 days (range, 8 to 369). Significant risk factors for HC by univariate analysis included diagnosis of chronic myelogenous leukemia (p=0.028), unrelated HCT (p=0.029), grade III-IV acute graft-versus-host disease (GVHD) (p<0.001), extensive chronic GVHD (p=0.001), and positive cytomegalovirus antigenemia between post transplant days 31 and 60 (p=0.031). Multivariate analysis showed that grade III-IV acute GVHD was the most important risk factor for the occurrence of HC after allo-HCT (odds ratio, 3.38; 95% CI, 1.36-8.39). Late-onset HC, which occurred beyond 3 weeks after allo-HCT, was more frequently associated with GVHD than earlyonset HC (p=0.007). Our data suggest that a portion of late-onset HC might be a manifestation of GVHD.


Sujets)
Adulte , Femelle , Humains , Mâle , Cystite/épidémiologie , Cystite/étiologie , Cystite/anatomopathologie , Maladie du greffon contre l'hôte/complications , Maladie du greffon contre l'hôte/anatomopathologie , Cellules souches hématopoïétiques/physiologie , Troubles hémorragiques/épidémiologie , Troubles hémorragiques/étiologie , Troubles hémorragiques/anatomopathologie , Analyse multifactorielle , Études rétrospectives , Facteurs de risque , Transplantation de cellules souches/effets indésirables , Conditionnement pour greffe
SÉLECTION CITATIONS
Détails de la recherche